Skip to main content

Bladder Function

0
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Astellas
AstellasChina - Shenyang
2 programs
cystometryN/A
cystometryN/A1 trial
Active Trials
NCT01099345Terminated15Est. May 2012
ViiV Healthcare
ViiV HealthcareNC - Durham
1 program
cystometryN/A
GSK
GSKLONDON, United Kingdom
1 program
cystometryN/A1 trial
Active Trials
NCT01029015Completed26Est. Jul 2007

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Astellascystometry
GSKcystometry

Clinical Trials (2)

Total enrollment: 41 patients across 2 trials

NCT01099345Astellascystometry

A Pilot Trial in a Sleep Laboratory Setting to Observe Night Time Bladder Function of Subjects With Overactive Bladder (OAB)

Start: Jul 2010Est. completion: May 201215 patients
N/ATerminated
NCT01029015GSKcystometry

Pilot Trial in Sleep Laboratory Setting to Compare the Physiology of Night Time Bladder Function in Subjects With Overactive Bladder (OAB) Versus Subjects That Have Insomnia and Healthy Normal Subjects

Start: Nov 2006Est. completion: Jul 200726 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.